Literature DB >> 21366842

Reconsider hypertension phenotypes and osteoporosis.

Charalampos Dokos, Christos Savopoulos, Apostolos Hatzitolios.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21366842      PMCID： PMC8673313          DOI： 10.1111/j.1751-7176.2010.00407.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  15 in total

1.  Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States.

Authors:  Earl S Ford; Guixiang Zhao; Chaoyang Li; William S Pearson
Journal:  J Diabetes       Date:  2009-07-21       Impact factor: 4.006

2.  25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes?

Authors:  Kwame Osei
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

3.  Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.

Authors:  John P Forman; Jonathan S Williams; Naomi D L Fisher
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

4.  Undercarboxylated osteocalcin is a biomarker of carotid calcification in patients with essential hypertension.

Authors:  Takafumi Okura; Mie Kurata; Daijiro Enomoto; Masanori Jotoku; Tomoaki Nagao; Veena Rasika Desilva; Jun Irita; Ken-Ichi Miyoshi; Jitsuo Higaki
Journal:  Kidney Blood Press Res       Date:  2010-03-02       Impact factor: 2.687

5.  Vitamin D status and PTH in young men: a cross-sectional study on associations with bone mineral density, body composition and glucose metabolism.

Authors:  M Frost; B Abrahamsen; T L Nielsen; C Hagen; M Andersen; K Brixen
Journal:  Clin Endocrinol (Oxf)       Date:  2010-11       Impact factor: 3.478

6.  The relationship between vitamin D receptor gene polymorphisms and bone density, osteocalcin level and growth in adolescents.

Authors:  Eda Ozaydin; Didem Dayangac-Erden; Hayat Erdem-Yurter; Orhan Derman; Turgay Coşkun
Journal:  J Pediatr Endocrinol Metab       Date:  2010-05       Impact factor: 1.634

7.  The correlation of osteoporosis to clinical features: a study of 4382 female cases of a hospital cohort with musculoskeletal symptoms in southwest China.

Authors:  Shasha Li; Hongchen He; Mingfu Ding; Chengqi He
Journal:  BMC Musculoskelet Disord       Date:  2010-08-16       Impact factor: 2.362

8.  Activation of renin-angiotensin system induces osteoporosis independently of hypertension.

Authors:  Yutaro Asaba; Masako Ito; Toshio Fumoto; Ken Watanabe; Ryoji Fukuhara; Sunao Takeshita; Yuji Nimura; Junji Ishida; Akiyoshi Fukamizu; Kyoji Ikeda
Journal:  J Bone Miner Res       Date:  2009-02       Impact factor: 6.741

9.  Angiotensin II accelerates osteoporosis by activating osteoclasts.

Authors:  Hideo Shimizu; Hironori Nakagami; Mariana Kiomy Osako; Rie Hanayama; Yasuo Kunugiza; Takuji Kizawa; Tetsuya Tomita; Hideki Yoshikawa; Toshio Ogihara; Ryuichi Morishita
Journal:  FASEB J       Date:  2008-02-06       Impact factor: 5.191

10.  Hypothesis: it is time to reconsider phenotypes in hypertension.

Authors:  Marcelo Orias; Aldo H Tabares; Aldo J Peixoto
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-05       Impact factor: 3.738
View more
  1 in total

1.  Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes.

Authors:  Ole A Andreassen; Linda K McEvoy; Wesley K Thompson; Yunpeng Wang; Sjur Reppe; Andrew J Schork; Verena Zuber; Elizabeth Barrett-Connor; Kaare Gautvik; Pål Aukrust; Tom H Karlsen; Srdjan Djurovic; Rahul S Desikan; Anders M Dale
Journal:  Hypertension       Date:  2014-01-06       Impact factor: 10.190
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.